Idiopathic parkinson's disease Trials in Chicago, United States
Conditions / Idiopathic parkinson's disease / Chicago, United States
Idiopathic parkinson's disease is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02242487 | Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes | COMPLETED | PHASE3 |
| NCT00400634 | Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease | COMPLETED | PHASE2 |
| NCT00627640 | Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa | COMPLETED | PHASE3 |
| NCT00985517 | Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease | COMPLETED | PHASE1/PHASE2 |
| NCT02240030 | Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes | COMPLETED | PHASE3 |
| NCT02339064 | Infusion of Apomorphine: Long-term Safety Study | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01782222 | Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy | COMPLETED | PHASE4 |
| NCT02453386 | Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients | TERMINATED | PHASE3 |
| NCT01968031 | A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease | COMPLETED | PHASE3 |
| NCT00605683 | MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist | COMPLETED | PHASE3 |